Latest Insider Transactions at Galectin Therapeutics Inc (GALT)
This section provides a real-time view of insider transactions for Galectin Therapeutics Inc (GALT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GALECTIN THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GALECTIN THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 30
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,562
+4.77%
|
$13,124
$2.54 P/Share
|
|
Oct 15
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,807
+4.46%
|
$11,614
$2.87 P/Share
|
|
Oct 13
2020
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.97 P/Share
|
|
Sep 30
2020
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,242
+5.0%
|
$12,484
$2.67 P/Share
|